Healthcare provider profile · identity verified

Craig Phelps, M.D.

Family Practice · ELK CITY, OK · NPI 1295840288

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	214	60
Omeprazole	Omeprazole	172	48
Lisinopril	Lisinopril	150	44
Meloxicam	Meloxicam	136	38
Amlodipine Besylate	Amlodipine Besylate	135	42
Atorvastatin Calcium	Atorvastatin Calcium	134	38
Levothyroxine Sodium	Levothyroxine Sodium	122	34
Metformin Hcl Er	Metformin Hcl	109	32
Losartan Potassium	Losartan Potassium	107	31
Tramadol Hcl	Tramadol Hcl	99	26
Azithromycin	Azithromycin	98	64
Pantoprazole Sodium	Pantoprazole Sodium	88	21
Gabapentin	Gabapentin	83	26
Tamsulosin Hcl	Tamsulosin Hcl	83	23
Pravastatin Sodium	Pravastatin Sodium	79	22
Montelukast Sodium	Montelukast Sodium	76	20
Furosemide	Furosemide	75	17
Pioglitazone Hcl	Pioglitazone Hcl	74	22
Simvastatin	Simvastatin	73	21
Jardiance	Empagliflozin	68	13
Celecoxib	Celecoxib	66	17
Prednisone	Prednisone	65	38
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	63	16
Hydrochlorothiazide	Hydrochlorothiazide	63	20
Arexvy	Rsvpref3 Antigen/As01e/Pf	62	62
Sertraline Hcl	Sertraline Hcl	62	17
Allopurinol	Allopurinol	61	15
Mirtazapine	Mirtazapine	61	16
Metformin Hcl	Metformin Hcl	55	13
Famotidine	Famotidine	53	13
Farxiga	Dapagliflozin Propanediol	52	suppressed
Duloxetine Hcl	Duloxetine Hcl	50	suppressed
Carvedilol	Carvedilol	49	11
Fluoxetine Hcl	Fluoxetine Hcl	48	17
Metoprolol Tartrate	Metoprolol Tartrate	48	15
Finasteride	Finasteride	45	13
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	44	12
Ozempic	Semaglutide	44	suppressed
Potassium Chloride	Potassium Chloride	43	15
Terazosin Hcl	Terazosin Hcl	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	42	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	13
Bupropion Xl	Bupropion Hcl	39	14
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Pregabalin	Pregabalin	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	37	13
Metoprolol Succinate	Metoprolol Succinate	37	11
Donepezil Hcl	Donepezil Hcl	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Cephalexin	Cephalexin	33	26
Fluconazole	Fluconazole	33	11
Lorazepam	Lorazepam	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Synthroid	Levothyroxine Sodium	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Telmisartan	Telmisartan	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Colestipol Hcl	Colestipol Hcl	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	27	suppressed
Naproxen	Naproxen	27	11
Ondansetron Odt	Ondansetron	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Torsemide	Torsemide	25	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Alprazolam	Alprazolam	22	suppressed
Cefdinir	Cefdinir	22	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Estradiol	Estradiol	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Invokana	Canagliflozin	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Methylphenidate Er	Methylphenidate Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	15	suppressed
Levofloxacin	Levofloxacin	15	12
Methylprednisolone	Methylprednisolone	15	14
Synjardy Xr	Empagliflozin/Metformin Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	14	14
Butorphanol Tartrate	Butorphanol Tartrate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	11
Tradjenta	Linagliptin	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Eliquis	Apixaban	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Alogliptin	Alogliptin Benzoate	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error